NO20011251L - Avgivelse til lunge av aktivt middel fra tört pulver - Google Patents

Avgivelse til lunge av aktivt middel fra tört pulver

Info

Publication number
NO20011251L
NO20011251L NO20011251A NO20011251A NO20011251L NO 20011251 L NO20011251 L NO 20011251L NO 20011251 A NO20011251 A NO 20011251A NO 20011251 A NO20011251 A NO 20011251A NO 20011251 L NO20011251 L NO 20011251L
Authority
NO
Norway
Prior art keywords
active agent
lung
dry powder
delivery
delivering
Prior art date
Application number
NO20011251A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011251D0 (no
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Barry John Aldous
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of NO20011251D0 publication Critical patent/NO20011251D0/no
Publication of NO20011251L publication Critical patent/NO20011251L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO20011251A 1998-09-14 2001-03-13 Avgivelse til lunge av aktivt middel fra tört pulver NO20011251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (2)

Publication Number Publication Date
NO20011251D0 NO20011251D0 (no) 2001-03-13
NO20011251L true NO20011251L (no) 2001-04-17

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011251A NO20011251L (no) 1998-09-14 2001-03-13 Avgivelse til lunge av aktivt middel fra tört pulver

Country Status (44)

Country Link
EP (1) EP1117442A1 (uk)
JP (1) JP2002524535A (uk)
KR (1) KR20010075063A (uk)
CN (1) CN1317977A (uk)
AP (1) AP1374A (uk)
AR (1) AR022090A1 (uk)
AU (1) AU753014B2 (uk)
BG (1) BG105430A (uk)
BR (1) BR9913722A (uk)
CA (1) CA2343920A1 (uk)
CO (1) CO5130023A1 (uk)
CZ (1) CZ2001829A3 (uk)
DZ (1) DZ2892A1 (uk)
EA (1) EA003476B1 (uk)
EE (1) EE200100151A (uk)
GE (1) GEP20043257B (uk)
GT (1) GT199900156A (uk)
HK (1) HK1042231A1 (uk)
HN (1) HN1999000159A (uk)
HR (1) HRP20010189A2 (uk)
HU (1) HUP0103837A3 (uk)
ID (1) ID28845A (uk)
IL (2) IL141562A0 (uk)
IS (1) IS5878A (uk)
LT (1) LT4897B (uk)
LV (1) LV12658B (uk)
MA (1) MA25590A1 (uk)
MY (1) MY129282A (uk)
NO (1) NO20011251L (uk)
NZ (1) NZ510168A (uk)
OA (1) OA11781A (uk)
PA (1) PA8481901A1 (uk)
PE (1) PE20001061A1 (uk)
PL (1) PL195574B1 (uk)
SA (1) SA99200718B1 (uk)
SK (1) SK3442001A3 (uk)
TN (1) TNSN99173A1 (uk)
TR (1) TR200101182T2 (uk)
TW (1) TWI226248B (uk)
UA (1) UA76085C2 (uk)
UY (1) UY25711A1 (uk)
WO (1) WO2000015262A1 (uk)
YU (1) YU24201A (uk)
ZA (1) ZA200101995B (uk)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
ATE555773T1 (de) 1999-06-09 2012-05-15 Sievers Robert E Überkritische fluidgestützte verneblung und blasen trochnen
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
EA200401111A1 (ru) 2002-02-25 2005-02-24 Диффьюжн Фармасьютикалз Ллс Биполярные соли транс-каротиноидов и их применение
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
WO2004060352A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
PL2708225T3 (pl) * 2004-04-23 2019-07-31 Cydex Pharmaceuticals, Inc. Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
UA95903C2 (uk) * 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Транс-каротиноїди, їх синтез, лікарська форма та застосування
RU2007137121A (ru) * 2005-03-09 2009-04-20 Оно Фармасьютикал Ко., Лтд. (Jp) Частица и препарат, содержащий указанную частицу
DK1945228T4 (da) 2005-10-26 2015-01-12 Cydex Pharmaceuticals Inc Sulfoalkyl-ether-cyclodextrin-sammensætninger og fremgangsmåder til fremstilling deraf
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
JP5315056B2 (ja) * 2006-10-25 2013-10-16 大日本住友製薬株式会社 固結抑制粒状製剤
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
CN101687757A (zh) 2007-04-13 2010-03-31 扩散药品有限公司 双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
JP2011502125A (ja) 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー 小分子拡散を促進する新しい種類の治療法
DK2432502T3 (en) 2009-05-20 2018-03-12 Aeras STABLE, SPRAY DRIED, IMMUNOGENE, VIRUS COMPOSITIONS
KR101875843B1 (ko) 2009-06-22 2018-07-06 디퓨젼 파마슈티컬즈 엘엘씨 확산 촉진 화합물 및 그 화합물 단독 또는 혈전 용해제와 합쳐진 화합물의 용도
KR101891357B1 (ko) 2010-06-02 2018-08-24 디퓨젼 파마슈티컬즈 엘엘씨 양극성 트랜스 카로티노이드의 경구용 제형
NZ630040A (en) 2012-05-03 2016-10-28 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
US11185523B2 (en) 2016-03-24 2021-11-30 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE69732306T2 (de) * 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
SK3442001A3 (en) 2001-11-06
HUP0103837A3 (en) 2002-11-28
MA25590A1 (fr) 2002-12-31
KR20010075063A (ko) 2001-08-09
EE200100151A (et) 2002-06-17
LV12658A (lv) 2001-05-20
IL141562A0 (en) 2002-03-10
HK1042231A1 (zh) 2002-08-09
LT4897B (lt) 2002-02-25
BG105430A (en) 2001-12-29
EA200100300A1 (ru) 2001-10-22
PL346768A1 (en) 2002-02-25
HUP0103837A2 (hu) 2002-05-29
UA76085C2 (en) 2006-07-17
LV12658B (lv) 2001-09-20
AR022090A1 (es) 2002-09-04
SA99200718B1 (ar) 2006-11-04
ID28845A (id) 2001-07-05
IL141562A (en) 2007-07-24
CZ2001829A3 (cs) 2001-09-12
GEP20043257B (en) 2004-06-25
TWI226248B (en) 2005-01-11
OA11781A (en) 2005-07-26
LT2001021A (en) 2001-11-26
DZ2892A1 (fr) 2003-12-15
AP2001002093A0 (en) 2001-03-31
WO2000015262A1 (en) 2000-03-23
CN1317977A (zh) 2001-10-17
PE20001061A1 (es) 2000-10-08
AU6039799A (en) 2000-04-03
NO20011251D0 (no) 2001-03-13
EP1117442A1 (en) 2001-07-25
CO5130023A1 (es) 2002-02-27
UY25711A1 (es) 1999-11-17
HRP20010189A2 (en) 2005-04-30
ZA200101995B (en) 2002-03-11
PL195574B1 (pl) 2007-10-31
GT199900156A (es) 2001-03-07
CA2343920A1 (en) 2000-03-23
PA8481901A1 (es) 2002-04-25
YU24201A (sh) 2003-08-29
HN1999000159A (es) 1999-11-11
AP1374A (en) 2005-02-28
BR9913722A (pt) 2001-05-29
AU753014B2 (en) 2002-10-03
JP2002524535A (ja) 2002-08-06
IS5878A (is) 2001-03-05
TNSN99173A1 (fr) 2005-11-10
NZ510168A (en) 2003-09-26
MY129282A (en) 2007-03-30
EA003476B1 (ru) 2003-06-26
TR200101182T2 (tr) 2001-09-21

Similar Documents

Publication Publication Date Title
NO20011251L (no) Avgivelse til lunge av aktivt middel fra tört pulver
DE69006363D1 (de) Nikotin enthaltende stimulierende einzeldosis.
AR028315A2 (es) Compuestos de 1-arilpirazolcarboxaldehidos hidrazonas de plagas de actividad sistemica en la represion de plagas de artropodos, helmintos, nematodoss y protozoos; procedimientos para prepararlos y composiciones plaguicidas que lo contienen, y metodos de aplicacion de dichos compuestos para la repres
DK1658047T3 (da) Spraytörret amorft pulver med en lav resterende fugtighed og udmærket lagerstabilitet
NZ516790A (en) Oral treatment of companion animals with ectoparasiticidal spinosyns
ATE513555T1 (de) Pharmazeutische kombination aus g-csf und plgf für blutstammzellen
ATE374600T1 (de) Pharmazeutische formulierung enthaltend olanzapin
DK0665714T3 (da) Granulære vandopløselige eller hygroskopiske landbrugsformuleringer og fremgangsmåder til fremstilling heraf
WO2005039288A3 (en) An insectidcidal composition with enhanced synergistic activity
WO2003082248A3 (en) Taste masked compositions of erythromycin a and derivatives thereof
FR2668367B1 (fr) Medicament implantable a effet prolonge.
RU96109664A (ru) Способ иммобилизации биологически активных веществ на биогенном носителе
DE202004019220U1 (de) Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut
TH51990A3 (th) การปล่อยสารออกฤทธิ์ที่เป็นผงแห้ง
Yasuyuki et al. The cell extract of Porphyromonas gingivalis promotes attachment of Prevotella nigrescens cells to hydroxyapatite
JPS58134011A (ja) 脱毛防止剤
AR224932A1 (es) Composiciones herbicidas que contienen como agente activo 3-amino-triazol clorhidrato,solo o en mezcla con tiocianatos solubles y procedimientos para prepararlos
PL393880A1 (pl) Zastosowanie kompozycji herbicydów do zwalczania szkodliwych roślin w uprawach zbóż, sposób zwalczania szkodliwych roślin w tolerujących uprawach zbóż, preparat chwastobójczy i jego zastosowanie
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas
JPS52120128A (en) Agricultural insecticide and its preparation
RU96109663A (ru) Способ получения иммобилизованного препарата пантокрина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application